RC
Rubric Capital Management LP
€43m
▲ Purchases (12 ops.)
Insider track record Other Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Rubric Capital Management LP. Director active across 6 companies, notably Heron Therapeutics, INC.. In total, 20 disclosures have been published. Breakdown: 12 buys · 4 sells. Total volume traded: €1bn. Activity tracked since 8 December 2021. The latest transaction was disclosed on 13 August 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rubric Capital Management LP Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 20 total
946,100 shares Common Stock, par value $0.01 per share ("Common Stock") SEC:0000902664-25-004459:0
25,000 shares @ US$37.85 100.0% of flow Common Stock, par value $0.001 per share SEC:0000902664-25-003729:0
2,387,225 shares @ US$1.50 100.0% of flow Common Stock, par value $0.01 per share ("Common Stock") SEC:0000902664-25-003535:0
Canonical exit: 6 Nov 2025 (T+90) 44,343 shares @ US$288.5476 1.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0000902664-25-002832:0
4,893,507 shares @ US$204.3524 100.0% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-24-128881:0
877,192 shares @ US$2.28 2.0% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-23-119331:0
312,525 shares @ US$3.6797 1.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-23-076387:0
29,000 shares @ €1,250.3807 39.1% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-23-024323:0
29,000 shares @ €1,250.3807 39.1% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-23-000311:0
14,825 shares @ US$6.09 0.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-126117:0
Canonical exit: 9 Mar 2023 (T+90) 20,113 shares @ US$5.6625 0.1% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-125712:0
Canonical exit: 7 Mar 2023 (T+90) 7,000 shares @ US$1,000.00 7.6% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-22-112801:0
Canonical exit: 26 Jan 2023 (T+90) 7,000 shares @ US$1,000.00 7.7% of flow Series A Preferred Stock, par value $0.001 per share SEC:0001104659-22-105392:0
Canonical exit: 29 Dec 2022 (T+90) 1,678,954 shares @ US$10.07 57.3% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-22-089894:0
Canonical exit: 9 Nov 2022 (T+90) 4,012 shares @ US$10.07 0.1% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-22-089124:0
Canonical exit: 8 Nov 2022 (T+90) 565,000 shares @ US$4.72 2.8% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-084850:0
Canonical exit: 27 Oct 2022 (T+90) 64,892 shares @ US$5.56 0.4% of flow Common Stock, par value $0.001 per share ("Common Stock") SEC:0001104659-22-080754:0
Canonical exit: 13 Oct 2022 (T+90) 146,685 shares @ US$7.0747 7.6% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150598:0
Canonical exit: 16 Mar 2022 (T+90) 187,391 shares @ US$7.0804 9.6% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-150068:0
Canonical exit: 13 Mar 2022 (T+90) 560,691 shares @ US$8.0206 32.8% of flow Common Stock, par value $0.0001 per share ("Common Stock") SEC:0001104659-21-148720:0
Canonical exit: 8 Mar 2022 (T+90) About Rubric Capital Management LP Rubric Capital Management LP is a director and insider, primarily involved with Heron Therapeutics, INC. and Radius Health, Inc.